| | |
Challenging Cases in Metastatic Breast Cancer
7/9/2009 Speaker: William Gradishar, MD
|
|
Ixempra™ (ixabepilone): The First Epothilone
3/18/2009 Speaker: Nancy Smith, RN, MS
|
|
Ixempra™ (ixabepilone): The First Epothilone
12/4/2008 Speaker: Dr. Frankie Ann Holmes
|
|
Case Study: Update in the Treatment of Colorectal Cancer
6/11/2009 Speaker: John L. Marshall, MD
|
|
Nexavar® (sorafenib) in the Treatment of Advanced Renal Cell Carcinoma
7/29/2009 Speaker: Howard Ozer, MD, PhD
|
|
Cases in Glioblastoma Multiforme: The Multidisciplinary Approach
4/24/2009 Speaker: Susan A. Weaver, MD
|
|
Advances in the Treatment of Oral Mucositis & Xerostomia in Radiation & Chemotherapy Patients
5/22/2008 Speaker: Marilyn Haas, PhD, RN, CNS, ANP-C
|
|
Advances in the Treatment of Oral Mucositis & Xerostomia in Radiation & Chemotherapy Patients
5/1/2008 Speaker: Loren Godfrey, MD
|
|
Clinical Overview of Cancer Types in Patients with Immunodeficiencies (PIDD) & Reimbursement Guide for IgG Therapies
11/16/2010 Speaker: William Grossman, MD, PhD and Kimberly Jones, RN
|
|
Considerations for the Treatment of Relapsed/Refractory PTCL
6/16/2010 Speaker: Andrei Shustov M.D.
|
|
Targeted Therapy for CLL: Emerging Insights for Treatment
11/5/2009 Speaker: Charles M. Farber, MD, PhD
|
|
Nexavar® (sorafenib) in the Treatment of Patients with Unresectable Hepatocellular Carcinoma (HCC)
9/3/2009 Speaker: Patrick J. Flynn, MD
|
|
Current Trends in MDS Treatment
3/25/2009 Speaker: Lewis Silverman, MD
|
|
A Unique Treatment for Patients with Chronic Lymphocytic Leukmina (CLL)
11/6/2008 Speaker: Prof. Dr. Wolfgang Knauf
|
|
An Update of Leukine® (sargramostim): Strategies for Successful Patient Management
11/12/2008 Speaker: Elaine S. DeMeyer, RN, MSN, AOCN
Michelle “Angie” Noll, RN, BSN, OCN, MBA, HCM
|
|
Nexavar in the Treatment of Patients with Advanced Renal Cell Carcinoma (RCC)
10/30/2008 Speaker: Dr. Patrick J. Flynn
|
|
Expanding Horizons: Advances in Targeted Therapies for CLL
10/15/2008 Speaker: Kanti R. Rai, MD
|
|
Optimizing Outcomes and Survival in Multiple Myeloma
9/11/2008 Speaker: Asher Chanan-Khan, MD
|
|
A Practical Approach to Treatment Options in MDS
3/28/2008 Speaker: Guillermo Garcia-Manero, MD
|
|
The Use of Histology to Select Cytotoxic Therapy for the Treatment of Advanced Nonsquamous NSCLC
10/8/2009 Speaker: Eric Nadler, MD
|
|
The Use of Histology to Select Cytotoxic Therapy for the Treatment of Advanced Nonsquamous NSCLC
10/6/2009 Speaker: David A. Smith, M.D.
|
|
Feraheme® (ferumoxytol) Reimbursement and Coding Update
6/1/2011 Speaker: Rick Ford, MBA, FMLI
|
|
Managing Reimbursement Trends in a Dynamic Oncology Environment
5/5/2010 Speaker: Julie Lisano, PharmD, BCOP
Rick Ford, MBA, FLMI
|
|
Management of Iron Deficiency Anemia in Chronic Kidney Disease (CKD)
11/11/2009 Speaker: David H. Henry, MD
Rick Ford, MBA, FLMI
|
|
Extravasation Update: New Therapeutic Options & Economic Implications
11/29/2008 Speaker: Rick Ford, MBA, FLMI
Lisa Schulmeister, RN, MN, APRN-BC, OCN, FAAN
|
|
The Oncology Nurse and Oral Chemotherapy
10/21/2009 Speaker: Jody Pelusi, PhD
|
|
Jevtana (cabazitaxel) for the Treatment of Hormone-Refractory Metastatic Prostate Cancer
12/16/2010 Speaker: Mark T. Fleming, M.D.
|
|